Showing results (201-210 of 1,142) with videos related to
Sort By:
Pageof 115
Gut|February 15, 2011
Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoactionLukas Moleda, Jonel Trebicka, Peter Dietrich, et al.European Journal of Gastroenterology & Hepatology|November 5, 2010
Is detection of bacterial DNA in ascitic fluid of clinical relevance?Beate Appenrodt, Lutz E Lehmann, Lydia Thyssen, et al.Plos One|July 29, 2014
The role of miRNA-34a as a prognostic biomarker for cirrhotic patients with portal hypertension receiving TIPSChristian Jansen, Hannah Eischeid, Jan Goertzen, et al.Journal of Translational Internal Medicine|October 16, 2020
Pulmonary Complications in Patients with Liver CirrhosisFabian Benz, Raphael Mohr, Frank Tacke, et al.Nature Reviews. Gastroenterology & Hepatology|December 8, 2016
Liver - guardian, modifier and target of sepsisPavel Strnad, Frank Tacke, Alexander Koch, et al.Deutsche Medizinische Wochenschrift (1946)|September 20, 2016
[Consciousness disorders from toxicological view]Lukas Bündgens, Frank Tacke, Christian Trautwein, et al.Frontiers in Medicine|October 15, 2021
Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver DiseasesAlix Bruneau, Jana Hundertmark, Adrien Guillot, et al.Expert Opinion on Pharmacotherapy|June 17, 2020
Current and emerging pharmacotherapeutic interventions for the treatment of liver fibrosisJoeri Lambrecht, Leo A van Grunsven, Frank TackeMedizinische Klinik, Intensivmedizin Und Notfallmedizin|February 10, 2025
[Acute management of bleeding complications and coagulation disorders in critically ill patients with liver cirrhosis]Philipp Kasper, Frank Tacke, Matthias Kochanek, et al.Cytometry. Part B, Clinical Cytometry|September 10, 2024
A comprehensive 26-color immunophenotyping panel to study the role of the gut-liver axis in chronic liver diseasesAlix Bruneau, Yaroslava Shevchenko, Frank Tacke, et al.Pageof 115